Understanding antimicrobial therapy requires a deep dive into how specific drugs interact with bacterial structures to disrupt life cycles. Antibiotics are generally categorized by their Mechanism of Action (MoA), which can be broadly classified into four major pathways: inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of DNA synthesis, and inhibition of RNA synthesis. By targeting these essential biological processes, medications can either kill the bacteria (bactericidal) or prevent them from growing (bacteriostatic).
Bacterial Cell Wall Synthesis Inhibitors
The bacterial cell wall is a critical structural component that maintains osmotic pressure. Drugs that interfere with the construction of this wall cause the bacteria to lyse and die.
Penicillins and Cephalosporins
The Penicillins and Cephalosporins are both -lactam antibiotics, meaning they share a common chemical structure and mechanism: they inhibit bacterial cell wall synthesis.
Penicillins include several distinct agents:
- Amoxicillin: Often used for sinusitis, pneumonia, COPD exacerbations, endocarditis, and rheumatic fever. A typical dose is 0.5–1g. Common side effects include nausea, vomiting, and diarrhea, while contraindications include penicillin hypersensitivity (e.g., rash, fever, joint pain).
- Augmentin: A combination therapy used for recurrent pharyngitis and infected skin and soft tissue infections (SSTI). It requires monitoring of liver function.
- Flucloxacillin: Specifically indicated for Staphylococcus aureus infections such as cellulitis, impetigo, boils, and mastitis. It requires monitoring of both hepatic and renal function.
Cephalosporins are another class of -lactams used for various infections:
- Cefuroxime: Used for pyelonephritis.
- Ceftriaxone: Indicated for meningococcal disease and endocarditis.
- Cefalexin: Commonly used for cellulitis and boils.
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
Continue reading freeAlready have an account? Log in
Updated